Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Novartis Ag ADR (NY: NVS )

83.36 USD -1.56 (-1.84%)
Official Closing Price Updated: 7:00 PM EDT, Oct 25, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,095,549
Open 83.67
Bid (Size) 83.00 (1)
Ask (Size) 85.65 (1)
Prev. Close 84.92
Today's Range 83.24 - 83.85
52wk Range 77.04 - 98.52
Shares Outstanding N/A
Dividend Yield 3.57%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
A Preview Of Novartis's Earnings
Novartis (NYSE:NVS) is set to give its latest quarterly earnings report on Tuesday, 2021-10-26. Here's what investors need to know ... 
Tags BZI/EP Earnings Benzinga
From Benzinga
Price To Earnings Ratio Insights For Novartis
In the current market session, Novartis Inc. (NYSE:NVS) is trading at $84.51, after a 0.19% decrease. However, over ... 
Tags Markets Earnings Intraday Update
From Benzinga

Performance

YTD
-11.67%
-11.67%
1 Month
+0.93%
+0.93%
3 Month
-8.36%
-8.36%
6 Month
-5.07%
-5.07%
1 Year
-0.97%
-0.97%

More News

Read More
Novartis Extends Fill/Finish Support For Pfizer/BioNTech COVID-19 Vaccines
Tags Health Care Biotech Benzinga
From Benzinga
Novartis and Medicines for Malaria Venture Report Positive Results for Phase 2b Study of Novel Ganaplacide/Lumefantrine Combination in Children With Malaria
Tags Novartis Medicines for Malaria Malaria
From 3BL Media: Corporate Social Responsibility, Energy and Health News
This Company Revolutionizes What Matters for Hospitals, Big Pharma and Health Insurers
Tags BMY RHHBY Partner Content
From Benzinga
3 Under-the-Radar COVID Stocks
Tags CYRX SQ TSLA
From Motley Fool
Is This Beaten Down Biotech a Bad News Buy?
Tags UTHR VRTX ALPMF
From Motley Fool
CRSP Stock: The Cancer Study News Sending Crispr Therapeutics Lower Today
Tags PLUG Today's Market NASDAQ:CRSP,NYSE:NVS,NASDAQ:GILD,NASDAQ:WTRH,NASDAQ:PLUG
From InvestorPlace
Have $500? This Under-the-Radar Stock Could Make You Richer From the Biotech Boom
Tags BLFS NTLA Market News
From Motley Fool
For Patient Investors, Tilray Will Deliver Multi-Fold Returns
Tags Market News NVS TLRY
From InvestorPlace
eFFECTOR Therapeutics Stock Gains On Encouraging Preclinical Zotatifin Data In Breast Cancer
Tags Trading Ideas News NVS
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.